GL1X · GenesisL1 explorer

MolNFT v1 · #88013 · protein

Structure of the DDB1-crbn E3 ubiquitin ligase bound to lenalidomide

4CI2 · DNA damage-binding protein 1: “Structure of the DDB1-crbn E3 ubiquitin ligase bound to lenalidomide”. X-ray diffraction, 2 ligands (LVY, ZN), 12 pockets (best druggability 0.86). MolNFT v1 #88013 on GenesisL1: 3D structure, binding…

PDB
4CI2
Type
protein
Length
1,461 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA damage-binding protein 1; Protein cereblon
UniProt
Q16531, P0CF65
Ligands
LVY, ZN
Pockets
12 · best druggability 0.86

Structure

x-ray diffraction · 2 distinct chains · 10% helix, 48% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADNA damage-binding protein 1protein10915% helix, 53% strandQ16531
BProtein cereblonprotein37026% helix, 34% strandP0CF65

Ligands and binding sites

  • LVY · S-Lenalidomide · ligand · chains B
  • ZN · Zinc ion · metal · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

12 pockets found on a 1 Å grid, 7 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111190.860.87113empty
211050.810.82102empty
39540.800.8287empty
44930.720.8139empty
57840.720.7864empty

Interfaces

1 interface between chains.

  • A–B · 2390 Ų buried · 16 hydrogen bonds · protein-protein

Compared structures

  • 4CI2 · Structure of the DDB1-CRBN E3 ubiquitin ligase bound to lenalidomide · the same entry in another collection · chain A against A, TM-score 1.00
  • P0CF65 · AlphaFold monomer V2.0 prediction for protein cereblon (P0CF65) · a predicted model of the same protein · chain B against A, TM-score 0.99
  • Q16531 · AlphaFold monomer V2.0 prediction for DNA damage-binding protein 1 (Q16531) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.